Editorial label review
Alloy side effects: headaches
Primary formulary: Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms
Quick answer
Headaches shows up on the FDA labels for the active ingredients Alloy prescribes — Estradiol (oral and patch) + oral micronized progesterone. This page walks through the labelled frequency ranges, what to watch for, and when to call your clinician.
What Alloy prescribes and why it matters for headaches
Alloy prescribes FDA-approved bioidentical estradiol and oral micronized progesterone, plus oxybutynin ER as a non-hormonal option for vasomotor symptoms. Because Alloy prescribes FDA-approved active ingredients, the labelled adverse-reaction tables from those medications describe the frequencies you should expect. Headache and migraine appear on every estradiol PIL used by these brands.
Common label-level side effects
Sourced from Section 6 (Adverse Reactions) of each FDA-approved PIL.
- Headache is one of the most commonly reported reactions across estradiol PILs — 10–30% in Section 6 tables
- Migraine is listed separately at 3–8% in most combination-therapy PILs
- Brisdelle (paroxetine 7.5 mg) PIL lists headache at ~5% in Section 6
Serious label-level warnings
Drawn from Section 5 (Warnings and Precautions) of the FDA-approved PILs — including the estradiol boxed warning where applicable.
- Sudden severe headache or new-onset migraine with aura — estradiol PIL Section 5 requires discontinuation and stroke workup
- Headache paired with vision loss or facial droop — call 911 per estradiol PIL boxed warning for stroke
When to contact your clinician
Seek emergency care for a sudden severe headache, new migraine with aura, or headache with vision or speech change — the estradiol label treats these as stroke signals.
Call 911 if you develop chest pain, one-sided weakness, sudden severe headache, vision or speech change, or shortness of breath — per the estradiol PIL boxed warning for cardiovascular events.
What to ask your provider
- “Which SKU in the Alloy formulary am I on, and what is its labelled frequency for headaches?”
- “Is my headacheslikely a labelled adverse reaction, or something separate that needs its own workup?”
- “Would a different delivery route (patch vs. pill, oral vs. transdermal) change my expected frequency?”
- “What is the plan if headachesdoes not settle within 2–3 cycles?”
Related editorial reading
- Full editorial review of Alloy — formulary, pricing, and clinician model.
- Is headaches caused by menopause itself? — how the transition presents on its own.
- Estradiol medication page — mechanism, dosing, and full PIL notes.
- Progesterone medication page — secondary ingredient in Alloy's formulary.
- Browse all side-effect matrix pages — 4 brands × 15 symptoms.
Frequently asked questions
- How often does headaches happen on Alloy?
- Alloy's primary regimen — Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms — carries the FDA-labelled adverse-reaction frequencies for headaches described on this page. Ranges vary from < 1% to 45% depending on the specific active ingredient and delivery route. See the sources block for the exact PIL tables.
- When should I stop Alloy because of headaches?
- Talk to your clinician immediately if you meet any of the "when to contact" criteria on this page — most estradiol PIL Section 5 warnings require prompt reassessment. Do not stop hormone therapy without medical input; abrupt discontinuation can trigger rebound symptoms.
- Is headaches on the FDA label for Alloy's medications?
- Headache and migraine appear on every estradiol PIL used by these brands.
- Is headaches caused by menopause itself?
- Headaches can appear during the menopause transition for reasons unrelated to hormone therapy. Our /does-menopause-cause/headaches explainer covers what the underlying biology is and how clinicians disentangle the transition from the treatment.